跳至主要内容
临床试验/NCT06312891
NCT06312891招募中不适用

Value of Heart Rate Lowering Therapy in Acute Myocarditis

Assiut University1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2024年4月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
招募中
入组人数
150
试验地点
1
主要终点
Value of Heart Rate Lowering Therapy in Acute Myocarditis

研究概览

简要总结

To study the value of heart rate lowering therapy "pharmacological rest" on the short term in cases of myocarditis without LV dysfunction.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults: ≥18 years of age.
  • Presentation: at least one of the following:
  • Myopericarditis/ACS-like
  • Arrhythmias: brady or tachyarrhythmias.
  • Unexplained compensated acute cardiomyopathy (excluded ischemic, valvular, hypertensive, metabolic, and toxic causes of cardiomyopathy as indicated clinically).
  • TTE: LVEF>40%
  • CMR-confirmed myo(peri)carditis (Lake Louise criteria)

排除标准

  • • Rheumatic carditis.
  • Connective tissue diseases (-ve ANA).
  • Cancer chemotherapy.
  • Toxicity from immunotherapy.
  • Vaccine-related myocarditis.
  • Presence of coronary artery disease.
  • Peripartum (occurring during the last month of pregnancy or within 5 months after delivery)
  • ECG: atrial fibrillation/flutter.
  • Resuscitated sudden death.
  • Early/initial phase of decompensated heart failure.
  • Tamponade complicating pericarditis unless successfully managed.

研究组 & 干预措施

Conventional ttt PLUS Ivabradine.

干预措施: Ivabradine (Drug)

结局指标

主要结局

Value of Heart Rate Lowering Therapy in Acute Myocarditis

时间窗: baseline

To study the value of heart rate lowering therapy "pharmacological rest" on the short term in cases of myocarditis without LV dysfunction.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sara Mahmoud Moustafa

Resident at student hospital , assiut university

Assiut University

研究点 (1)

Loading locations...

相似试验

Value of Heart Rate Lowering Therapy in Acute... | 临床试验